Is NRXS or OM more undervalued in 2026?

CirclFi compares Neuraxis, Inc. (NRXS) and Outset Medical, Inc. (OM) using 13 institutional-grade valuation models. NRXS has a Quality of Company score of 6.9/10 while OM scores 6.7/10.

Which is a better buy — NRXS or OM?

Compare intrinsic values from 13 independent models against current market prices. CirclFi also calculates Value Trap scores. This is not financial advice — conduct your own analysis.

How do NRXS and OM valuations compare?

NRXS at $7.41 and OM at $4.89 are compared across Bayesian DCF, EPV, EROIC Spread, First Chicago, Markov DDM, and 8 additional models.

NRXS vs OM Valuation Comparison 2026 — Intrinsic Value Analysis

NRXS

Electromedical & Electrotherapeutic Apparatus

Neuraxis, Inc.

Quality

6.9

out of 10

Value Trap

SAFE

Price

$7.41

Last close

Models

10/13

Active

OM

Electromedical & Electrotherapeutic Apparatus

Outset Medical, Inc.

Quality

6.7

out of 10

Value Trap

SAFE

Price

$4.89

Last close

Models

10/13

Active

Model-by-Model Comparison

Model	Type	NRXS Fair Value	NRXS Upside	OM Fair Value	OM Upside
Bayesian DCF	Intrinsic	$2.02	-72.7%	—	—
Earnings Power Value	Intrinsic	$1.57	-80.6%	$5.29	+21.3%
EROIC Spread	Intrinsic	$•••.••	••.•%	$•••.••	••.•%
First Chicago	Scenario	$•••.••	••.•%	$•••.••	••.•%
ML-RIV	Intrinsic	$•••.••	••.•%	$•••.••	••.•%
Dynamic NAV	Asset-Based	$0.86	-88.4%	$6.30	+28.9%
PWERM	Option-Based	$•••.••	••.•%	$•••.••	••.•%
Regime Cross-Sectional	Relative	$•••.••	••.•%	$•••.••	••.•%
Sentiment SOTP	Hybrid	$•••.••	••.•%	$•••.••	••.•%
CUCE Ensemble	Ensemble	$•••.••	••.•%	$•••.••	••.•%
FTNN Topology	Relative	$•••.••	••.•%	$•••.••	••.•%

🔒

Unlock Full 13-Model Comparison

Access all valuation models for NRXS vs OM — including EROIC Spread, First Chicago, Markov DDM, PWERM, and 7 more.

Access Full Analysis — From $27/mo →

NRXS vs OM — Which Stock Is More Undervalued?

NRXS scores higher with a 6.9/10 quality rating vs OM's 6.7/10. Both stocks are analyzed daily using SEC EDGAR filings across 13 independent models.

Comparing Neuraxis, Inc. (NRXS) and Outset Medical, Inc. (OM) across 13 institutional-grade valuation models reveals how each company's intrinsic value stacks up against its market price. CirclFi's engine processes SEC EDGAR 10-K and 10-Q filings, FRED macroeconomic data, and GDELT news sentiment to generate independent fair value estimates daily.

NRXS currently trades at $7.41 with a QOC of 6.9/10, while OM trades at $4.89 with a QOC of 6.7/10.

Both companies are analyzed with models spanning intrinsic (Bayesian DCF, EPV), scenario-based (First Chicago), regime-switching (Markov DDM, RCMH-DCF), machine learning (ML-RIV, FTNN Topology), and ensemble methods (CUCE).